Showing results (181-190 of 568) with videos related to
Sort By:
Pageof 57
Current Oncology Reports|March 29, 2022
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of RechallengeLaura B Vater, Bénédicte Lefebvre, Anita Turk, et al.Journal of Anatomy|May 13, 2003
Muscle fibre breakdown in venom-induced muscle degenerationJ B Harris, R Vater, M Wilson, et al.Arzneimittel-Forschung|January 1, 1981
[Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions (author's transl)]H Meyer, F Bossert, E Wehinger, et al.Arzneimittel-Forschung|January 1, 1981
[2-aminodihydropyridines / Structure and antihypertensive activity (author's transl)]H Meyer, E Wehinger, F Bossert, et al.British Journal of Anaesthesia|August 1, 1984
Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteersM Vater, G Smith, G W Aherne, et al.Stroke|October 1, 1993
Evidence from comparative investigations that impaired platelet activation is not specific for stroke-prone spontaneously hypertensive ratsA Klee, S Vater, G W Schmid-Schönbein, et al.Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 18, 2003
Intraoperative TEE for the management of pulmonary tumour embolism during chondroblastic osteosarcoma resectionLee Newkirk, Youri Vater, Donald Oxorn, et al.Biophysical Chemistry|August 31, 2001
Influence of allosteric effectors on the kinetics and equilibrium binding of phosphoenolpyruvate (PEP) to phosphoenolpyruvate carboxylase (PEPC) from Zea maysJ Frank, R J Clarke, J Vater, et al.Frontiers in Pharmacology|October 2, 2025
The role of the lysine histone methylase KMT2D in chronic myeloid leukemiaLina Schlemminger, Inga Nagel, Inga Vater, et al.Hospital Pediatrics|November 10, 2020
Implementing and Maintaining an Increased Frequency of Nighttime Education SessionsMcKenzie R Vater, Alison Herndon, Whitney Browning, et al.Pageof 57